Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Telsar Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01612039
First received: June 1, 2012
Last updated: September 26, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 20, 2016